Sunshine Biopharma, Inc. (SBFM) Financials

SBFM Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 31.5 million 7.3 million
June 30, 2025 32.0 million 6.3 million
March 31, 2025 29.2 million 6.5 million
Dec. 31, 2024 30.6 million 7.1 million

SBFM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -735840 ?
June 30, 2025 -1.8 million ?
March 31, 2025 -1.9 million ?
Dec. 31, 2024 -3.8 million ?

SBFM Net Income

No data available :(

SBFM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 9.3 million - 854761
June 30, 2025 10.3 million - 929026
March 31, 2025 8.2 million - 936182
Dec. 31, 2024 9.7 million - 952480

SBFM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 4.7 million
June 30, 2025 224805
March 31, 2025 2.7 million
Dec. 31, 2024 2.6 million

SBFM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 8040 119298 3.3 million 235217
June 30, 2025 550187 196232 4.0 million 201658
March 31, 2025 212017 215277 3.6 million 398361
Dec. 31, 2024 439304 -785000 4.8 million 203162

SBFM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 9.4 million 6.3 million
June 30, 2025 9.4 million 6.0 million
March 31, 2025 8.9 million 6.2 million
Dec. 31, 2024 9.6 million 6.5 million

SBFM

Price: $2.64

52 week price:
0.25
2.69

Earnings Per Share: -15.02 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 5.4 million

Links: